NASDAQ:KRMD KORU Medical Systems (KRMD) Stock Price, News & Analysis → The attacks will come for me after releasing this… (From Porter & Company) (Ad) Free KRMD Stock Alerts $2.14 -0.13 (-5.73%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$2.10▼$2.2650-Day Range$2.06▼$2.4752-Week Range$1.98▼$4.22Volume160,320 shsAverage Volume177,692 shsMarket Capitalization$97.93 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get KORU Medical Systems alerts: Email Address KORU Medical Systems MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside63.6% Upside$3.50 Price TargetShort InterestHealthy2.97% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.43Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.16) to ($0.07) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.81 out of 5 starsMedical Sector386th out of 915 stocksSurgical & Medical Instruments Industry51st out of 98 stocks 3.5 Analyst's Opinion Consensus RatingKORU Medical Systems has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageKORU Medical Systems has received no research coverage in the past 90 days.Read more about KORU Medical Systems' stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.97% of the float of KORU Medical Systems has been sold short.Short Interest Ratio / Days to CoverKORU Medical Systems has a short interest ratio ("days to cover") of 8.4.Change versus previous monthShort interest in KORU Medical Systems has recently decreased by 5.19%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldKORU Medical Systems does not currently pay a dividend.Dividend GrowthKORU Medical Systems does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KRMD. Previous Next 3.0 News and Social Media Coverage News SentimentKORU Medical Systems has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for KORU Medical Systems this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for KRMD on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, KORU Medical Systems insiders have not sold or bought any company stock.Percentage Held by Insiders25.60% of the stock of KORU Medical Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions58.60% of the stock of KORU Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about KORU Medical Systems' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for KORU Medical Systems are expected to grow in the coming year, from ($0.16) to ($0.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of KORU Medical Systems is -7.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of KORU Medical Systems is -7.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKORU Medical Systems has a P/B Ratio of 4.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about KORU Medical Systems' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. About KORU Medical Systems Stock (NASDAQ:KRMD)KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Read More KRMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KRMD Stock News HeadlinesMay 14, 2024 | finance.yahoo.comKORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological BiologicMay 3, 2024 | finance.yahoo.comIt Looks Like KORU Medical Systems, Inc.'s (NASDAQ:KRMD) CEO May Expect Their Salary To Be Put Under The MicroscopeMay 2, 2024 | msn.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2024 Earnings Call TranscriptMay 2, 2024 | finance.yahoo.comKORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...May 1, 2024 | finance.yahoo.comKORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue GrowthMay 1, 2024 | finance.yahoo.comKORU Medical Systems Inc (KRMD) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst ChallengesApril 22, 2024 | msn.comHeat face Celtics in first round after epic conference finals duel last seasonApril 17, 2024 | finance.yahoo.comKORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024April 11, 2024 | businesswire.comKORU Medical Systems Announces Successful Appeal in EU Notified Body ReviewMarch 28, 2024 | investorplace.comThe Penny Stock A-List: 7 High-Profile Companies on the Verge of GreatnessMarch 18, 2024 | businesswire.comKORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 ConferenceMarch 17, 2024 | msn.comYankees get the World Series-winning crew back together to help out in spring trainingMarch 16, 2024 | finance.yahoo.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comKORU Medical Systems Full Year 2023 Earnings: EPS Misses ExpectationsMarch 14, 2024 | msn.comSaratoga County Sheriff’s Office to participate in statewide STOP-DWI St. Patrick’s Day campaignMarch 14, 2024 | markets.businessinsider.comBuy Rating Justified: REPRO-MED Systems’ Strong Growth Prospects and Solid Financial PerformanceMarch 14, 2024 | finance.yahoo.comKORU Medical Systems Inc (KRMD) Reports Mixed 2023 Financial Results and Provides 2024 OutlookMarch 13, 2024 | finance.yahoo.comKORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 GuidanceMarch 12, 2024 | benzinga.comEarnings Outlook For KORU Medical SystemsMarch 11, 2024 | businesswire.comKORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized BiologicMarch 8, 2024 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on REPRO-MED Systems (KRMD)March 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for KORU Medical Systems Amidst Growth and Market Expansion ProspectsMarch 6, 2024 | businesswire.comKORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous ImmunoglobulinFebruary 28, 2024 | morningstar.comKORU Medical Systems Inc KRMDFebruary 21, 2024 | finance.yahoo.comKORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024See More Headlines Receive KRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KORU Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/01/2024Today6/15/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:KRMD CUSIPN/A CIK704440 Webwww.korumedical.com Phone(845) 469-2042Fax845-469-5518Employees82Year FoundedN/APrice Target and Rating Average Stock Price Target$3.50 High Stock Price Target$4.00 Low Stock Price Target$3.00 Potential Upside/Downside+63.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,740,000.00 Net Margins-45.24% Pretax Margin-29.75% Return on Equity-25.10% Return on Assets-18.73% Debt Debt-to-Equity Ratio0.02 Current Ratio4.01 Quick Ratio3.37 Sales & Book Value Annual Sales$28.52 million Price / Sales3.43 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book4.76Miscellaneous Outstanding Shares45,760,000Free Float34,048,000Market Cap$97.93 million OptionableOptionable Beta0.58 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMs. Linda M. Tharby (Age 56)President, CEO & Director Comp: $713.37kMr. Thomas Adams (Age 51)CFO, Secretary & Treasurer Comp: $380.47kMr. Brian Case (Age 51)Chief Technology Officer Comp: $371.16kMr. Kenneth Miller (Age 55)Chief Commercial Officer Comp: $126.54kMr. Christopher PazdanSenior Vice President of OperationsMr. Rob CannonVice President of SalesMore ExecutivesKey CompetitorsAnika TherapeuticsNASDAQ:ANIKTreace Medical ConceptsNASDAQ:TMCINevroNYSE:NVROSight SciencesNASDAQ:SGHTOraSure TechnologiesNASDAQ:OSURView All CompetitorsInsiders & InstitutionsVirtu Financial LLCBought 26,805 shares on 5/20/2024Ownership: 0.059%First Light Asset Management LLCBought 57,253 shares on 5/15/2024Ownership: 11.409%Archon Capital Management LLCBought 230,517 shares on 5/14/2024Ownership: 8.635%Vanguard Group Inc.Bought 51,890 shares on 5/10/2024Ownership: 4.287%Mesirow Financial Investment Management Inc.Bought 10,959 shares on 4/26/2024Ownership: 0.024%View All Insider TransactionsView All Institutional Transactions KRMD Stock Analysis - Frequently Asked Questions Should I buy or sell KORU Medical Systems stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for KORU Medical Systems in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KRMD shares. View KRMD analyst ratings or view top-rated stocks. What is KORU Medical Systems' stock price target for 2024? 4 brokerages have issued 1 year price objectives for KORU Medical Systems' stock. Their KRMD share price targets range from $3.00 to $4.00. On average, they predict the company's share price to reach $3.50 in the next year. This suggests a possible upside of 63.6% from the stock's current price. View analysts price targets for KRMD or view top-rated stocks among Wall Street analysts. How have KRMD shares performed in 2024? KORU Medical Systems' stock was trading at $2.46 at the start of the year. Since then, KRMD stock has decreased by 13.0% and is now trading at $2.14. View the best growth stocks for 2024 here. Are investors shorting KORU Medical Systems? KORU Medical Systems saw a decrease in short interest in May. As of May 31st, there was short interest totaling 1,280,000 shares, a decrease of 5.2% from the May 15th total of 1,350,000 shares. Based on an average daily volume of 152,200 shares, the days-to-cover ratio is presently 8.4 days. Currently, 3.0% of the shares of the stock are sold short. View KORU Medical Systems' Short Interest. When is KORU Medical Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our KRMD earnings forecast. How were KORU Medical Systems' earnings last quarter? KORU Medical Systems, Inc. (NASDAQ:KRMD) issued its quarterly earnings results on Wednesday, May, 1st. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02. The business earned $8.20 million during the quarter, compared to the consensus estimate of $7.49 million. KORU Medical Systems had a negative trailing twelve-month return on equity of 25.10% and a negative net margin of 45.24%. During the same quarter in the prior year, the company posted ($0.05) EPS. What guidance has KORU Medical Systems issued on next quarter's earnings? KORU Medical Systems updated its FY 2024 earnings guidance on Thursday, May, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $31.2 million-$32.2 million, compared to the consensus revenue estimate of $31.7 million. What other stocks do shareholders of KORU Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other KORU Medical Systems investors own include NVIDIA (NVDA), Enphase Energy (ENPH), Alibaba Group (BABA), Walt Disney (DIS), PennyMac Financial Services (PFSI), Inseego (INSG), Micron Technology (MU), Advanced Micro Devices (AMD), Marvell Technology (MRVL) and Taiwan Semiconductor Manufacturing (TSM). Who are KORU Medical Systems' major shareholders? KORU Medical Systems' stock is owned by a number of institutional and retail investors. Top institutional investors include First Light Asset Management LLC (11.41%), Archon Capital Management LLC (8.64%), Vanguard Group Inc. (4.29%), Albion Financial Group UT (1.62%), Virtu Financial LLC (0.06%) and Advisor Resource Council (0.06%). Insiders that own company stock include Joseph M Jr Manko, Linda M Tharby and Robert Cascella. View institutional ownership trends. How do I buy shares of KORU Medical Systems? Shares of KRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:KRMD) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KORU Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KORU Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
